Skip to main content
Caplight Logo









Lilac Biosciences Inc.

Lilac Biosciences Inc.

Private
Providence, Rhode IslandHealthcare & Life Scienceshttps://lilacbiosciences.com/

Company Overview

Lilac Biosciences Inc. is a biotechnology company that develops quantitative RNA-based analytical tools and workflow solutions for discovery and translational research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

RNA analysisRNA modificationbiotech research toolstranslational scienceRNA biomarkersanalytical kitsbioinformatics platformmolecular biologyreagent solutionsdrug discoverywet labbench sciencelife science reagentsbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lilac Biosciences Inc. Comparables

Compare Lilac Biosciences Inc. with similar companies based on industry and business-model similarity.

Lilac Biosciences Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alida Biosciences
84%
Epigentek Group Inc.
81%
Arraystar Inc.
78%

Lilac Biosciences Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Sabrina Tolppi

Co-Founder, Chief Scientific Officer, and Interim CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors grew 371% MoM.

Recent news

Latest coverage and updates

  • partners_withJul 23, 2026

    Lilac Biosciences Inc. partnered with Soin Neuroscience Inc. on Jul 23rd '26.

Lilac Biosciences Inc. Filings

Explore SEC and related filing metadata, where available.

Lilac Biosciences Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lilac Biosciences Inc.'s valuation, stock price, and market status.

Is Lilac Biosciences Inc. a public or private company?

Lilac Biosciences Inc. is a private company.

What is the current stock price of Lilac Biosciences Inc.?

Lilac Biosciences Inc. is a private company with no public stock price. Caplight tracks Lilac Biosciences Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Lilac Biosciences Inc. worth (valuation)?

Valuation information for Lilac Biosciences Inc. is not publicly available.

Can I buy Lilac Biosciences Inc. stock?

Lilac Biosciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lilac Biosciences Inc.'s last funding round?

Funding round information for Lilac Biosciences Inc. is not publicly available.

Who are the main investors in Lilac Biosciences Inc.?

Investor information for Lilac Biosciences Inc. is not publicly disclosed.

Will Lilac Biosciences Inc. IPO soon?

No public IPO plans have been announced for Lilac Biosciences Inc..

How can I track Lilac Biosciences Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lilac Biosciences Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersProvidence, Rhode Island
Employee Range4
Year Founded2025
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?